SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Shenzhen Salubris Pharmaceuticals Co., Ltd. Share Price
Equities
002294
CNE100000FW8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.26 CNY | +1.13% |
|
+11.13% | -4.29% |
| 23/04 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
| 23/04 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
| Sales 2024 * | 3.92B 542M 45.15B | Sales 2025 * | 4.74B 654M 54.55B | Capitalization | 34.12B 4.71B 393B |
|---|---|---|---|---|---|
| Net income 2024 * | 674M 93.02M 7.76B | Net income 2025 * | 826M 114M 9.5B | EV / Sales 2024 * | 7.88 x |
| Net cash position 2024 * | 3.2B 441M 36.78B | Net cash position 2025 * | 3.18B 438M 36.55B | EV / Sales 2025 * | 6.53 x |
| P/E ratio 2024 * |
52.4
x | P/E ratio 2025 * |
42.2
x | Employees | 3,517 |
| Yield 2024 * |
1.7% | Yield 2025 * |
1.39% | Free-Float | 38.31% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.13% | ||
| 1 week | +11.13% | ||
| Current month | +7.39% | ||
| 1 month | +14.17% | ||
| 3 months | +12.20% | ||
| 6 months | +5.47% | ||
| Current year | -4.29% |
1 week
28.09
31.48
1 month
27.5331.48
Current year
23.5033.00
1 year
23.5037.31
3 years
20.0039.33
5 years
16.7043.66
10 years
16.7046.32
| Managers | Title | Age | Since |
|---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 01/06/01 |
Ai Zhen Li
CHM | Chairman | 54 | 01/04/01 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 03/98/03 |
Sing Ye
CHM | Chairman | 49 | 01/04/01 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 01/06/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.63% | 2 M€ | -16.59% | - | |
| 0.46% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 31.26 | +1.13% | 4,966,779 |
| 25/24/25 | 30.91 | +3.14% | 5,639,419 |
| 24/24/24 | 29.97 | -1.90% | 5,871,349 |
| 23/24/23 | 30.55 | +6.08% | 8,764,717 |
| 22/24/22 | 28.8 | +2.38% | 3,833,716 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company is also engaged in the research and development, production and sales of cardiovascular medical devices. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
28/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
31.26
CNY
Average target price
37
CNY
Spread / Average Target
+18.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.29% | 4.71B | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- 002294 Stock
